Quarterly Result16 May 2026, 09:00 pm
Neogen Chemicals Approves FY26 Audited Results; Dividend of ₹1
AI Summary
Neogen Chemicals Ltd's board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend of Re. 1 per equity share for FY26, subject to shareholder approval. Amendments to the insider trading code were approved, and details of outstanding qualified borrowings were disclosed. Neogen Ionics Limited, a wholly-owned subsidiary, reported changes in project timelines and costs for its Dahej and Pakhajan projects.
Key Highlights
- Neogen Chemicals approved audited financial results for FY26 with an unmodified audit opinion.
- A final dividend of Re. 1 per share was recommended for FY26, pending shareholder approval.
- Insider trading code amendments were approved and uploaded to the company website.
- Neogen Ionics' Dahej project cost is now ₹428 Cr with completion by Feb 2027.
- Neogen Ionics' Pakhajan project cost is now ₹1,367 Cr with completion by Mar 2027.
Price Impact
More from NEOGEN